CMIC Aiming For Top Five In Global Pharma Contract Business
This article was originally published in PharmAsia News
Executive Summary
CMIC Holdings is aiming to develop a growth strategy that will push it to fifth or sixth position in the global drug contract market, CEO Kazuo Nakamura told reporters at a recent Tokyo press conference.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.